Home > News > Content

IVD Infectious Disease Market Analysis By Product, By Test Location And Segment Forecasts To 2022

Jan 08, 2018

IVD Infectious Disease Market Analysis By Product (Instruments,Reagents, Software),ByTechnology, Application(MRSA,Streptococcus,Clostridium difficile, Vancomycin-resistant enterococci, Carbapenem-resistant bacteria testing, Respiratory virus,Candida,Tuberculosis and drug-resistant TB, Gastro-intestinal panel testing, Chlamydia, Gonorrhea, HPV, HIV, Hepatitis C, Hepatitis B), By Test Location And Segment Forecasts To 2022.The global IVD infectious disease market was valued at over USD 13 billion in 2014 and is expected to grow at a CAGR of 8.2% over the forecast period. Rising prevalence of infectious diseases, growing base of geriatric population, lower immunity levels, and rising awareness among people about communicable diseases are estimated to be high impact rendering drivers.

Rising base of the geriatric population with decreasing immune levels is expected to provide a wide base for growth of this market. The Global Health and Aging report by the NIH states that geriatric population accounts for a major share of infectious disease in low-income countries. Older people are already suffering from various infections and are more vulnerable to additional infectious diseases.